clinical 1,642 words KG: NE3107 (Bezisterim) Early Parkinson's Trial 2026-03-31
kind:clinical-trialsection:clinical-trialsstate:publishedparkinsonstnf-alphaanti-inflammatoryphase-2
Contents

NE3107 (Bezisterim) Early Parkinson's Trial

Knowledge Graph

Related Hypotheses (5)

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Microbial Inflammasome Priming Prevention
Score: 0.58
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Trans-Synaptic Adhesion Molecule Modulation
Score: 0.34

Related Analyses (7)

What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed

Related Experiments (5)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne
validation · proposed · Score: 0.40
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40

Knowledge Graph (1 edges)

NE3107 (Bezisterim) Early Parkinson's Trial references NLRP3